In vivo covalent binding of chemicals to DNA as a short-term test for carcinogenicity by Lutz, Werner K. & Schlatter, C.
'·' 
,, 
Mechanism of Taxie Action on Some Target Organs 
Arch. Toxicol., Suppl. 2, 411-415 (1979) 
© by Springer-Verlag 1979 
In vivo Covalent Binding of Chemieals to DNA 
as a Short-Term Test for Carcinogenicity 
W. K. Lutz and Ch. Schlatter 
Institute of Toxicology, Federal Institute of Technology and University of Zürich, 
CH-8603 Schwerzenbach, Switzerland 
Abstract. The determination of a covalent binding of radioactive chemieals to 
DNA in intact mammalian organisms is proposedas a short-term test for carci-
nogenicity. The effectiveness of covalent binding to rat liver DNA correlates well 
with the hepatocarcinogenicity known from long-term bioassays. The binding 
indices range over more than five orders of rriagnitude between the strongest 
hepatocarcinogen aflatoxin B 1 and the limit of detection of a binding with 100 
f-LCi 14C-labelled chemical. The order of magnitude of binding is therefore a 
surprisingly good quantitative measure for carcinogenicity. The pattern of DNA 
binding sites is important especially for small alkylating agents where the deter-
mination of total binding might indicate a higher carcinogenic potency than is 
actually observed. 
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Introducdon 
It is now widely accepted that the induction of tumors by organic chemieals involves 
a covalent binding of these chemieals or one of their metabolites to DNA of the 
target organs (Irving, 1973; Lawley, 1976). 
This covalent interaction can be measured in intact mammalian organisms with 
the use of radioactively labelled chemieals and could be used as the basis of a short-
term test for carcinogenicity. 
Materials and Methods 
The standard protocol for this binding assay involves 
1. Administration of the radioactive compound. Rats are used most commonly 
and the route of administration should preferably be the same as the one of human 
exposure. 
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2. Waiting for absorption and metabolism (a few hours to one day). 
3. Isolation of DNA from the argans of interest. Liver is taken in most studies 
because it contains all the enzymes necessary for a metabolic activation of the 
compounds and yields plenty of DNA. 
4. Determination of the radioactivity on the DNA as a measure for bound 
chemical. 
For a comparison of the effectiveness of covalent DNA-binding of different 
compounds, the darnage to DNA is expressed per unit dose according to the formula 
for a 'Covalent Binding Index, CBI': 
darnage to DNA 
CBI=-----
Resuits 
dose 
Micromole Chemical bound per Mole DNA Phosphate 
Millimole Chemical administered per kg body weight 
More than 80 compounds have already been investigated on their effectiveness of 
covalent binding to DNA in vivo (Lutz, 1979), and Table J. gives a selection of 
literatme data of CBI of hepatocarcinogens of various potency. It is evident that a 
striking correlation exists between th@ DNA-binding of these compounds and the 
carcinogenic properties known from long-term bioassays. Between the CBI of the 
strengest known hepatocarcinogen aflatoxin B1 and our limit of detection with 
100 1-1Ci 14C-labelled chemical there are more than 5 orders of magnitude. 
Table 2 summarizes our own results with chemieals of controversial or weak 
carcinogenicity: 
Ajlatoxin M1 is a metabolite of the potent hepatocarcinogen aflatoxin B1, and is 
secreted in an appreciable amount in the milk of cows which have been fed aflatoxin 
Table 1. Correlation of hepatocarcinogenicity of chemieals to their covalent binding to rat liver DNA 
Compound Route Time (h) CBI Reference 
Strang hepatocarcinogens 
Aflatoxin B 1 !.p. 6 16,500 Garner, 1975 
Dirnethylnitrosamine i.p. 4 6,500 Pegg, 1977 
Moderate hepatocarcinogens 
2-Acetylaminofluorene !.p. 16 560 Goodman, 1976 
N-Nitrosopyrrolidine p.o. 12 170 Lijinsky, 1976 
W eak hepatocarcinogens 
Vinyl chloride inhal. 24 240 Bolt, 1976 
4-Dimeth ylaminoazo benzene Lp. 24 10 Dingman, 1967 
Urethane i.p. 24 37 Prodi, 1970 
Limit of detection with 100 ~-tCi l4C = 0.1 Lutz, 1977b 
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Table 2. Effectiveness of covalent binding to rat liver DNA 
Compound Route Time (h) CBI Reference 
Strong hepatocarcinogens 
Aflatoxin B 1 p.o. 6 10,000 
Aflatoxin M1 p.o. 6 1,600 
Carcinogens, but not hepatocarcinogens 
Benzo( a)pyrene I.p. 50 10 Lutz, 1978 
(after enzyme induction) i.v. 16 3.6-19.3 Viviani, 1978 
Benzene inhal. 10 1.7 Lutz, 1977a 
Doubtful or non-carcinogens 
Ethinyloestradiol p.o. 8 1.5 Jaggi, 1978 
Oestrone p.o. 8 1.1 Jaggi, 1978 
Toluene inhal. 5 :5 0.04 
Saccharin p.o. 50 < 0.005 Lutz, 1977b 
bladder DNA < 0.05 Lutz, 1977b 
Control 
Tritium from tritiated water p.o. 12-48 0.3-1 
B1 containing diets. Only rare information is available on its carcinogenicity from 
long-term bioassays and our binding studies show that aflatoxin M1 must be classi-
fied as a strong hepatocarcinogen. 
Ethinyloestradiol is used in some contraceptive drugs which are suspected to 
produce adenomas of.,the liver in very low yield. The binding found from this chemi-
cal is very low and almost equal to that of benzene, which is not known to induce 
liver tumors after very high dosage. The darnage of liver DNA by ethinyloestradiol 
is therefore on such a low level that it would be premature to accuse this drug of 
hepatocarcinogenicity, this all the more as its natural parent compound, oestrone, 
has an almost equal CBI and circulates in the body in a much higher concent~ation 
during a pregnancy. 
Saccharin has been reported to induce bladder tumors in male rats fed with a 
life-long diet containing 5 per cent saccharin. Saccharin is chemically inert and is not 
metabolized so that a covalent reaction with DNA is highly improbable. Indeed, we 
did not find any radioactivity on the DNA of liver or bladder after administration of 
35S-labelled saccharin on a limit of detection which is two million times below the 
binding of aflatoxin B1. We therefore conclude that saccharin is not a typical chemi-
cal carcinogen. The bladder tumors found are rather due to secondary effects on the 
bladder epithelium from the very high doses used. 
Toluene is an example of a compound which is considered safe although we 
could detect a minute DNA-binding which is about 40 times lower than that of 
benzene. This ratio adequately reflects the differences in their oncogenic activities 
and the darnage to DNA by toluene is probably on such a low level that it does not 
lead to a tumor within the life span of the animal. 
l 
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Discussion 
In performing such assays it is of crucial importance to exclude all radioactive 
contamination by rigorous purification of DNA. Noncovalent binding (physico-
chemical complex formation, intercalation) must be determined in control experi-
ments, and the biosynthetical incorporation oftritium from tritiated water into DNA 
(Table 2) must also be accounted for. Tritiated water can be formed from tritiated 
compounds by spontaneaus exchange or by enzymatic oxidations. 
Non-linear dose-binding relationships and time-dependence of the binding reflect 
pharmacokinetic complications and DNA repair processes. These could have an 
influence on the CBI but the effects seem tobe rather small: More than ten literatme 
references are available for the binding of dimethylnitrosamine (DMNA) to rat liver 
DNA. Male and female rats of various strains were used, doses ranged from 
0.25-30 mg/kg, and the time lag between administration ofDMNA and isolation of 
DNA was between 4 h and 14 days. Despite this wide range of experimental condi-
tions all the CBI lie between 1400 and 7100. On the basis of any of these experi-
ments performed, DMNA would have been called a potent hepatocarcinogen. 
From binding studies with methylating agents it is known that the exact site of 
methylation is critical for an assessment of the carcinogenicity, and that the type of 
chemical reactivity determines the pattern of DNA alkylation. The measurement of 
total binding as is proposed by this assay might therefore yield too high a CBI for a 
given carcinogenicity. This is shov:;n by methyl methanesulphonate which ranks with 
the moderate hepatocarcinogens · due to a CBI of 270-560 (O'Connor, 1973; 
Swann, 1968) although it is only very weakly hepatocarcinogenic. There is therefore 
no doubt that the DNA binding pattern or the mutagenic potency of the DNA 
darnage must also be evaluated, especially for small alkyl residues. 
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